For research use only
| Cat No. | ABC-RC604H |
| Product Type | Reporter Stable Cell Line |
| Host Cell | HCC70 |
| Storage | Liquid Nitrogen |
HCC70 Luciferase Reporter Cell Line enables sensitive monitoring of breast cancer signaling pathways, supporting oncology and drug screening research.
HCC70 Luciferase Reporter Cell Line is generated from HCC70 Cell Line, expressing the luciferase gene. The cells constitutively express luciferase.
| Cat.No | ABC-RC604H |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Reporter Stable Cell Line |
| Host Cell | HCC70 |
| Stock | In Stock |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
The HCC70 Luciferase Reporter Cell Line is a breast cancer cell line that has been genetically modified to express the luciferase enzyme. This modification allows researchers to study cellular processes and gene expression by detecting luminescent signals produced by the luciferase reaction.
This cell line is primarily used in breast cancer research. It helps in studying tumor biology, signal transduction pathways, and the efficacy of therapeutic agents. The luciferase reporter system enables real-time, non-invasive monitoring of gene expression and cellular responses, facilitating high-throughput screening and functional assays.
Real-Time Analysis: Enables real-time tracking of cellular processes through luminescence.
High Sensitivity: Provides high sensitivity and specificity in detecting gene expression and cellular responses.